Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Chronic Hepatitis C
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Dasabuvir 250mg Exviera
®
(Tablets)
Infections, Chronic hepatitis C, 05.03.03.02
RED
Elbasvir & grazoprevir 50mg/ 100mg Zepatier
®
Infections, Chronic hepatitis C, 05.03.03.02
RED
Glecaprevir & Pibrentasvir 100mg/ 40mg Maviret
®
(Tablets)
Infections, Chronic hepatitis C, 05.03.03.02
RED
Ledipasvir and Sofosbuvir 400mg/ 90mg Harvoni
®
(Tablets)
Infections, Chronic hepatitis C, 05.03.03.02
RED
Ombitasvir/ paritaprevir/ ritonavir Viekirax
®
(Tablets)
Infections, Chronic hepatitis C, 05.03.03.02
RED
Ribavirin 200mg
(Capsules)
Infections, Respiratory syncytial virus, 05.03.05
RED
Ribavirin 200mg, 400mg Copegus
®
(Tablets )
Infections, Respiratory syncytial virus, 05.03.05
RED
Simeprevir 150mg Olysio
®
(Capsules)
Infections, Chronic hepatitis C, 05.03.03.02
RED
Sofosbuvir / velpatasvir 400mg/100mg Epclusa
®
(Tablets)
Infections, Chronic hepatitis C, 05.03.03.02
RED
Sofosbuvir 400mg Sovaldi
®
(Tablets)
Infections, Chronic hepatitis C, 05.03.03.02
RED
Sofosbuvir 400mg/ Velpatasvir 100mg/ Voxilaprevir 100mg Vosevi
®
(Tablets)
Infections, Chronic hepatitis C, 05.03.03.02
Links found
NHSE Clinical Commissioning Policy Statement for treatment of chronic Hepatitis C in patients with cirrhosis
NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
NICE TA330: Sofosbuvir for treating chronic hepatitis C
NICE TA331: Simeprevir in combination with peginterferon alfa and ribavirin for treating genotypes 1 and 4 chronic hepatitis C
NICE TA363: Ledipasvir–sofosbuvir for treating chronic hepatitis C
NICE TA364: Daclatasvir for treating chronic hepatitis C
NICE TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
NICE TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
NICE TA413: Elbasvir–grazoprevir for treating chronic hepatitis C
NICE TA430: Sofosbuvir-velpatasvir for treating chronic hepatitis C
NICE TA499: Glecaprevir–pibrentasvir for treating chronic hepatitis C
NICE TA507: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C
NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C